COVID-19 update: Dec. 9, 2022
Medicare Part B immunosuppressive drug benefit; AST releases joint statement on COVID-19 vaccines and transplant; National Institutes of Health (NIH) updates; CDC updates guidance on COVID-19 boosters
COVID-19 update: Oct. 6, 2022
CDC updates guidance on COVID-19 boosters; NIH updates guidance on influenza season and COVID-19
COVID-19 update: Sept. 8, 2022
FDA authorizes booster; Updated guidance from CDC for immunocompromised and NIH on monoclonal antibodies; and COVID-19 Summary of Evidence updated
COVID-19 update: Aug. 19, 2022
NIH updates guidance for people who are immunocompromised; FDA advises repeat testing following a negative COVID-19 test
COVID-19 update: July 21, 2022
New FDA announcements on Paxlovid and Novavax vaccine, Adjuvanted; Summer 2022 regional meetings to be in-person
COVID-19 update: July 8, 2022
CDC’s interim recommendations for Moderna and Pfizer-BioNTech vaccines for children from 6 months of age; FDA recommends Omicron BA.4/5 component for vaccine boosters